Učitavanje...
The combination of an mTORc1/TORc2 inhibitor with lapatinib is synergistic in bladder cancer in vitro()
OBJECTIVE: To examine the ability of dual mTORc1/c2 inhibitors in conjunction with lapatinib to function in a synergistic manner to inhibit cell proliferation and anchorage-independent growth in bladder cancer cell lines. MATERIALS AND METHODS: We examined patient tumor samples for overexpression of...
Spremljeno u:
| Izdano u: | Urol Oncol |
|---|---|
| Glavni autori: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2013
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4559860/ https://ncbi.nlm.nih.gov/pubmed/24054871 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urolonc.2013.06.002 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|